Literature DB >> 24548887

Autotaxin: structure-function and signaling.

Anastassis Perrakis1, Wouter H Moolenaar2.   

Abstract

Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors. ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiological processes, ranging from lymphocyte homing to tumor progression. Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells. The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket. In addition, the catalytic domain has an open tunnel of unknown function adjacent to the active site. Here, we discuss our current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA production to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans. We also briefly discuss the development of drug-like inhibitors of ATX.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptors; ecto-nucleotide pyrophosphatase/phosphodiesterase; inhibitors; lysophosphatidic acid

Mesh:

Substances:

Year:  2014        PMID: 24548887      PMCID: PMC4031933          DOI: 10.1194/jlr.R046391

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  84 in total

Review 1.  Autotaxin and LPA receptor signaling in cancer.

Authors:  Anna J S Houben; Wouter H Moolenaar
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

3.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

4.  Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.

Authors:  Lauren P Saunders; Wenxiang Cao; William C Chang; Ronald A Albright; Demetrios T Braddock; Enrique M De La Cruz
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

5.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.

Authors:  Silvia Jansen; Cristiana Stefan; John W M Creemers; Etienne Waelkens; Aleyde Van Eynde; Willy Stalmans; Mathieu Bollen
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

6.  Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.

Authors:  Nikos Oikonomou; Marios-Angelos Mouratis; Argyris Tzouvelekis; Eleanna Kaffe; Christos Valavanis; George Vilaras; Andreas Karameris; Glenn D Prestwich; Demosthenes Bouros; Vassilis Aidinis
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-28       Impact factor: 6.914

7.  Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.

Authors:  Laurens A van Meeteren; Floor Frederiks; Ben N G Giepmans; Matheus F Fernandes Pedrosa; Stephen J Billington; B Helen Jost; Denise V Tambourgi; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

8.  Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells.

Authors:  Yafeng Zhang; Yi-Chun Maria Chen; Matthew F Krummel; Steven D Rosen
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

9.  Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells.

Authors:  Silvia Jansen; Maria Andries; Katrien Vekemans; Hubert Vanbilloen; Alfons Verbruggen; Mathieu Bollen
Journal:  Cancer Lett       Date:  2009-05-30       Impact factor: 8.679

Review 10.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  58 in total

1.  Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice.

Authors:  Peijian He; Abedul Haque; Songbai Lin; Fabio Cominelli; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

2.  Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program.

Authors:  Cody Kime; Masayo Sakaki-Yumoto; Leeanne Goodrich; Yohei Hayashi; Salma Sami; Rik Derynck; Michio Asahi; Barbara Panning; Shinya Yamanaka; Kiichiro Tomoda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-13       Impact factor: 11.205

Review 3.  The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.

Authors:  Seung-Jae Kim; Hyung-Geun Moon; Gye Young Park
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-29       Impact factor: 4.698

4.  Integrated, Continuous Emulsion Creamer.

Authors:  Wesley G Cochrane; Amber L Hackler; Valerie J Cavett; Alexander K Price; Brian M Paegel
Journal:  Anal Chem       Date:  2017-11-28       Impact factor: 6.986

Review 5.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

6.  Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.

Authors:  Raphael Leblanc; Sue-Chin Lee; Marion David; Jean-Claude Bordet; Derek D Norman; Renukadevi Patil; Duane Miller; Debashish Sahay; Johnny Ribeiro; Philippe Clézardin; Gabor J Tigyi; Olivier Peyruchaud
Journal:  Blood       Date:  2014-10-02       Impact factor: 22.113

7.  Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.

Authors:  Fernando Salgado-Polo; Alex Fish; Minos-Timotheos Matsoukas; Tatjana Heidebrecht; Willem-Jan Keune; Anastassis Perrakis
Journal:  J Biol Chem       Date:  2018-07-19       Impact factor: 5.157

8.  Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.

Authors:  Spencer B Jones; Lance A Pfeifer; Thomas J Bleisch; Thomas J Beauchamp; Jim D Durbin; V Joseph Klimkowski; Norman E Hughes; Christopher J Rito; Yen Dao; Joseph M Gruber; Hai Bui; Mark G Chambers; Srinivasan Chandrasekhar; Chaohua Lin; Denis J McCann; Daniel R Mudra; Jennifer L Oskins; Craig A Swearingen; Kannan Thirunavukkarasu; Bryan H Norman
Journal:  ACS Med Chem Lett       Date:  2016-08-02       Impact factor: 4.345

9.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

Review 10.  Lysophosphatidic Acid Signalling in Nervous System Development and Function.

Authors:  Eric Birgbauer
Journal:  Neuromolecular Med       Date:  2020-11-05       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.